Cancer Research Versailles No Abst Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lindvall, C.
Right arrow Articles by Xu, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lindvall, C.
Right arrow Articles by Xu, D.
[Cancer Research 63, 1743-1747, April 15, 2003]
© 2003 American Association for Cancer Research

Advances in Brief

Molecular Characterization of Human Telomerase Reverse Transcriptase-immortalized Human Fibroblasts by Gene Expression Profiling

Activation of the Epiregulin Gene1 ,, 2

Charlotta Lindvall3, Mi Hou3, Toshi Komurasaki, Chengyun Zheng, Marie Henriksson, John M. Sedivy, Magnus Björkholm, Bin Tean Teh, Magnus Nordenskjöld and Dawei Xu4

Department of Molecular Medicine [C. L., M. N.], Department of Medicine, Division of Hematology [M. Ho., C. Z., M. B., D. X.], Microbiology and Tumor Biology Center [M. He.], Karolinska Hospital and Institutet, SE-171 76 Stockholm, Sweden; Molecular Biology Laboratory, Medical Research Laboratories, Taisho Pharmaceutical Co., Ltd., Yoshino-Cho, Omiyanshi, Saitama, 330-8530 Japan [T. K.]; Shaanxi Provincial Hospital, Xian, 710068 People’s Republic of China [C. Z.]; Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, Rhode Island 02912 [J. M. S.]; Laboratory of Cancer Genetics, Van Andel Research Institute, Grand Rapids, Michigan 49503 [B. T. T.]

Reconstitution of telomerase activity by ectopic expression of telomerase reverse transcriptase (hTERT) results in an immortal phenotype in various types of normal human cells, including fibroblasts. Despite lack of transformation characteristics, it is unclear whether hTERT-immortalized cells are physiologically and biochemically the same as their normal counterparts. Here, we compared the gene expression profiles of normal and hTERT-immortalized fibroblasts by using a cDNA microarray containing 20,736 cDNA clones and identified 172 dysregulated genes or expressed sequence tags (ESTs). One of the highly expressed genes in the hTERT-immortalized fibroblasts (hTERT-BJ cells) encodes epiregulin, a potent growth factor. Blockade of epiregulin reduced the growth of hTERT-BJ cells and colony formation of hTERT-transformed fibroblasts. Moreover, inhibition of epiregulin function in immortal hTERT-BJ cells triggered a senescence program. Our results suggest that both activation of telomerase and subsequent induction of epiregulin are required for sustained cell proliferation. Given the significant difference in gene expression profiles between normal and hTERT-immortalized fibroblasts and the close relationship between epiregulin and tumorigenesis, we conclude that hTERT-immortalized cells may not replace their normal counterparts for studies of normal cell biology and that the use of hTERT for expansion of normal human cells for therapeutic purposes must be approached with caution.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
D. W. McMillin, M. Ooi, J. Delmore, J. Negri, P. Hayden, N. Mitsiades, J. Jakubikova, S.-M. Maira, C. Garcia-Echeverria, R. Schlossman, et al.
Antimyeloma Activity of the Orally Bioavailable Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235
Cancer Res., July 15, 2009; 69(14): 5835 - 5842.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
E. J. Chapman, G. Kelly, and M. A. Knowles
Genes Involved in Differentiation, Stem Cell Renewal, and Tumorigenesis Are Modulated in Telomerase-Immortalized Human Urothelial Cells
Mol. Cancer Res., July 1, 2008; 6(7): 1154 - 1168.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
W. Li, Z. Ge, C. Liu, Z. Liu, M. Bjorkholm, J. Jia, and D. Xu
CIP2A Is Overexpressed in Gastric Cancer and Its Depletion Leads to Impaired Clonogenicity, Senescence, or Differentiation of Tumor Cells
Clin. Cancer Res., June 15, 2008; 14(12): 3722 - 3728.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Li, F. Takeuchi, J.-a. Wang, Q. Fan, T. Komurasaki, E. M. Billings, G. Pacheco-Rodriguez, J. Moss, and T. N. Darling
Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas
PNAS, March 4, 2008; 105(9): 3539 - 3544.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
O. Menzel, M. Migliaccio, D. R. Goldstein, S. Dahoun, M. Delorenzi, and N. Rufer
Mechanisms Regulating the Proliferative Potential of Human CD8+ T Lymphocytes Overexpressing Telomerase
J. Immunol., September 15, 2006; 177(6): 3657 - 3668.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Zhou, X.-m. Li, and R. M. Lavker
Transcriptional Profiling of Enriched Populations of Stem Cells Versus Transient Amplifying Cells: A COMPARISON OF LIMBAL AND CORNEAL EPITHELIAL BASAL CELLS
J. Biol. Chem., July 14, 2006; 281(28): 19600 - 19609.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. W. J. Schreurs, M. A. J. A. Hermsen, R. I. K. Geltink, K. B. J. Scholten, A. A. T. P. Brink, E. W. M. Kueter, M. Tijssen, C. J. L. M. Meijer, B. Ylstra, G. A. Meijer, et al.
Genomic stability and functional activity may be lost in telomerase-transduced human CD8+ T lymphocytes
Blood, October 15, 2005; 106(8): 2663 - 2670.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. S. Burns, B. M. Abdallah, P. Guldberg, J. Rygaard, H. D. Schroder, and M. Kassem
Tumorigenic Heterogeneity in Cancer Stem Cells Evolved from Long-term Cultures of Telomerase-Immortalized Human Mesenchymal Stem Cells
Cancer Res., April 15, 2005; 65(8): 3126 - 3135.
[Abstract] [Full Text] [PDF]

Home page
 Cold Spring Harb Symp Quant BiolHome page
D.A. GALLOWAY, L.C. GEWIN, H. MYERS, W. LUO, C. GRANDORI, R.A. KATZENELLENBOGEN, and J.K. McDOUGALL
Regulation of Telomerase by Human Papillomaviruses
Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 209 - 215.
[Abstract] [PDF]

Home page
 Mol. Cell. Biol.Home page
D. Lee, R. S. Pearsall, S. Das, S. K. Dey, V. L. Godfrey, and D. W. Threadgill
Epiregulin Is Not Essential for Development of Intestinal Tumors but Is Required for Protection from Intestinal Damage
Mol. Cell. Biol., October 15, 2004; 24(20): 8907 - 8916.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
J. A. Benanti and D. A. Galloway
Normal Human Fibroblasts Are Resistant to RAS-Induced Senescence
Mol. Cell. Biol., April 1, 2004; 24(7): 2842 - 2852.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Milyavsky, I. Shats, N. Erez, X. Tang, S. Senderovich, A. Meerson, Y. Tabach, N. Goldfinger, D. Ginsberg, C. C. Harris, et al.
Prolonged Culture of Telomerase-Immortalized Human Fibroblasts Leads to a Premalignant Phenotype
Cancer Res., November 1, 2003; 63(21): 7147 - 7157.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.